These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 15627199)
1. [VMD2 and its role in Best's disease and other retinopathies]. Stöhr H; Milenkowic V; Weber BH Ophthalmologe; 2005 Feb; 102(2):116-21. PubMed ID: 15627199 [TBL] [Abstract][Full Text] [Related]
2. [Function of bestrophin]. Strauss O; Rosenthal R Ophthalmologe; 2005 Feb; 102(2):122-6. PubMed ID: 15627200 [TBL] [Abstract][Full Text] [Related]
3. [Best's disease. Overview of pathology and its causes]. Lorenz B; Preising MN Ophthalmologe; 2005 Feb; 102(2):111-5. PubMed ID: 15657691 [TBL] [Abstract][Full Text] [Related]
4. [Best's disease with normal EOG. Case report of familial macular dystrophy]. Pollack K; Kreuz FR; Pillunat LE Ophthalmologe; 2005 Sep; 102(9):891-4. PubMed ID: 15657694 [TBL] [Abstract][Full Text] [Related]
5. Mutations in a novel gene, VMD2, encoding a protein of unknown properties cause juvenile-onset vitelliform macular dystrophy (Best's disease). Marquardt A; Stöhr H; Passmore LA; Krämer F; Rivera A; Weber BH Hum Mol Genet; 1998 Sep; 7(9):1517-25. PubMed ID: 9700209 [TBL] [Abstract][Full Text] [Related]
6. The mutation spectrum of the bestrophin protein--functional implications. Bakall B; Marknell T; Ingvast S; Koisti MJ; Sandgren O; Li W; Bergen AA; Andreasson S; Rosenberg T; Petrukhin K; Wadelius C Hum Genet; 1999 May; 104(5):383-9. PubMed ID: 10394929 [TBL] [Abstract][Full Text] [Related]
7. New VMD2 gene mutations identified in patients affected by Best vitelliform macular dystrophy. Marchant D; Yu K; Bigot K; Roche O; Germain A; Bonneau D; Drouin-Garraud V; Schorderet DF; Munier F; Schmidt D; Le Neindre P; Marsac C; Menasche M; Dufier JL; Fischmeister R; Hartzell C; Abitbol M J Med Genet; 2007 Mar; 44(3):e70. PubMed ID: 17287362 [TBL] [Abstract][Full Text] [Related]
8. Mutations of VMD2 splicing regulators cause nanophthalmos and autosomal dominant vitreoretinochoroidopathy (ADVIRC). Yardley J; Leroy BP; Hart-Holden N; Lafaut BA; Loeys B; Messiaen LM; Perveen R; Reddy MA; Bhattacharya SS; Traboulsi E; Baralle D; De Laey JJ; Puech B; Kestelyn P; Moore AT; Manson FD; Black GC Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3683-9. PubMed ID: 15452077 [TBL] [Abstract][Full Text] [Related]
9. VMD2 mutations in vitelliform macular dystrophy (Best disease) and other maculopathies. White K; Marquardt A; Weber BH Hum Mutat; 2000; 15(4):301-8. PubMed ID: 10737974 [TBL] [Abstract][Full Text] [Related]
11. Linkage study of Best's vitelliform macular dystrophy (VMD2) in a large North American family. Hou YC; Richards JE; Bingham EL; Pawar H; Scott K; Segal M; Lunetta KL; Boehnke M; Sieving PA Hum Hered; 1996; 46(4):211-20. PubMed ID: 8807324 [TBL] [Abstract][Full Text] [Related]
12. The gene causing the Best's macular dystrophy (BMD) encodes a putative ion exchanger. Gómez A; Cedano J; Oliva B; Piñol J; Querol E DNA Seq; 2001 Dec; 12(5-6):431-5. PubMed ID: 11913792 [TBL] [Abstract][Full Text] [Related]
13. Best's vitelliform dystrophy (VMD2) maps between D11S903 and PYGM: no evidence for locus heterogeneity. Weber BH; Walker D; Müller B; Mar L Genomics; 1994 Mar; 20(2):267-74. PubMed ID: 8020974 [TBL] [Abstract][Full Text] [Related]
14. Insertion and topology of normal and mutant bestrophin-1 in the endoplasmic reticulum membrane. Milenkovic VM; Rivera A; Horling F; Weber BH J Biol Chem; 2007 Jan; 282(2):1313-21. PubMed ID: 17110374 [TBL] [Abstract][Full Text] [Related]
15. Use of denaturing HPLC and automated sequencing to screen the VMD2 gene for mutations associated with Best's vitelliform macular dystrophy. Marchant D; Gogat K; Dureau P; Sainton K; Sternberg C; Gadin S; Dollfus H; Brasseur G; Hache JC; Dumur V; Puech V; Munier F; Schorderet DF; Marsac C; Menasche M; Dufier JL; Abitbol M Ophthalmic Genet; 2002 Sep; 23(3):167-74. PubMed ID: 12324875 [TBL] [Abstract][Full Text] [Related]